TARGET
saveCD38
Multiple myeloma surface antigen; target of daratumumab.
also known as: cd38 antigen
drugs
0
catalysts
0
news
10
companies
0
Top drugs
no drugs tagged with this interest yet
🐶 Top companies
no companies tagged with this interest yet
Recent catalysts
no catalysts tagged with this interest yet
Recent news
view all →- GSK doubles down on Chimagen with $750M multiple myeloma wagerfiercebiotech · 1mo ago
- Unlocking cell surface protein research with site-specific labelingbiospace · 1mo ago
- BMS clinches pivotal win for myeloma CAR T in ‘key derisking event’biospace · 1mo ago
- Bristol Myers’ pivotal CAR-T multiple myeloma trial hits primary endpointfiercebiotech · 1mo ago
- AbbVie’s bispecific T-cell engager shows promise in ph. 3 multiple myeloma trialfiercebiotech · 1mo ago
- ‘Substantially better than before’: Why India has golden opportunity to build on innovative R&D winsfiercebiotech · 3mo ago
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that